Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

241 Results

Funding for Systemic Treatment Clinical Trials

Guidelines and Advice

Alemtuzumab for the Treatment of T-cell Prolymphocytic Leukemia

Status: Archived
ID: 6-22

Jan 2007

Document

Antiemetics for Treatment of Chemotherapy-Induced Nausea and Vomiting (CINV)

Acute Lymphoblastic Leukemia: What to Expect During Intensive Chemotherapy Treatment

This page is for people newly diagnosed with ALL.

Guidelines and Advice

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Status: Current
Version: 2

Updated

Sep 2025

Guidelines and Advice

First-line treatment of advanced-stage Hodgkin lymphoma

Status: Current
ID: ES 6-25

Oct 2024

Guidelines and Advice

Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women with Early Stage Invasive Breast Cancer

Status: Archived
ID: 1-9

Jun 2010

Guidelines and Advice

A Pan-Canadian Practice Guideline: Prevention, Screening, Assessment and Treatment of Sleep Disturbances in Adults with Cancer

Status: Education and Information

Dec 2012

Guidelines and Advice

Follow-up Care for Survivors of Lymphoma who have Received Curative-Intent Treatment

Status: Current
ID: 26-5

Apr 2016

Guidelines and Advice

An Endorsement of the 2025 Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the EOTTD, ESGO, GCIG, ISSTD

Status: Current
ID: GL END 4-19

Updated

Nov 2025

Guidelines and Advice

An Endorsement of the ASTRO/ESTRO 2023 Guideline for the Treatment of Patients with Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

Status: Current
ID: GL END 7-24

Nov 2024

Guidelines and Advice

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Status: Current
ID: GL END 5-7
Version: 3

Nov 2021

Pages